Medina Value Partners LLC increased its position in TriMas Co. (NASDAQ:TRS – Free Report) by 2.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,034,882 shares of the industrial products company’s stock after acquiring an additional 28,851 shares during the period. TriMas comprises about 10.4% of Medina Value Partners LLC’s investment portfolio, making the stock its 2nd biggest holding. Medina Value Partners LLC owned 2.55% of TriMas worth $25,448,000 at the end of the most recent reporting period.
A number of other hedge funds also recently bought and sold shares of the company. Bellecapital International Ltd. bought a new position in TriMas in the 4th quarter worth $29,160,000. Raymond James Financial Inc. purchased a new stake in TriMas in the fourth quarter worth about $6,698,000. Kennedy Capital Management LLC raised its stake in shares of TriMas by 94.8% in the fourth quarter. Kennedy Capital Management LLC now owns 485,721 shares of the industrial products company’s stock worth $11,944,000 after buying an additional 236,346 shares during the period. Advisory Research Inc. lifted its position in shares of TriMas by 41.2% during the 4th quarter. Advisory Research Inc. now owns 754,089 shares of the industrial products company’s stock valued at $18,543,000 after buying an additional 220,000 shares in the last quarter. Finally, Norges Bank bought a new position in shares of TriMas during the 4th quarter valued at approximately $3,602,000. Hedge funds and other institutional investors own 99.42% of the company’s stock.
Insider Buying and Selling at TriMas
In other news, Director Shawn Sedaghat purchased 554,149 shares of the company’s stock in a transaction that occurred on Monday, March 10th. The stock was bought at an average cost of $24.07 per share, with a total value of $13,338,366.43. Following the completion of the purchase, the director now owns 900,974 shares in the company, valued at approximately $21,686,444.18. This represents a 159.78 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO Scott A. Mell sold 2,218 shares of the firm’s stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $22.54, for a total value of $49,993.72. Following the transaction, the chief financial officer now owns 26,288 shares of the company’s stock, valued at $592,531.52. This represents a 7.78 % decrease in their position. The disclosure for this sale can be found here. Insiders purchased a total of 806,246 shares of company stock valued at $19,338,213 in the last three months. 1.10% of the stock is currently owned by corporate insiders.
TriMas Price Performance
TriMas Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 28th were issued a $0.04 dividend. The ex-dividend date was Friday, February 28th. This represents a $0.16 dividend on an annualized basis and a yield of 0.79%. TriMas’s dividend payout ratio is presently 27.12%.
Wall Street Analyst Weigh In
Separately, BWS Financial reaffirmed a “buy” rating and set a $40.00 price target on shares of TriMas in a report on Friday, February 28th.
View Our Latest Stock Report on TriMas
About TriMas
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Read More
- Five stocks we like better than TriMas
- Investing in Travel Stocks Benefits
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- What is the Euro STOXX 50 Index?
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- What is Insider Trading? What You Can Learn from Insider Trading
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Want to see what other hedge funds are holding TRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TriMas Co. (NASDAQ:TRS – Free Report).
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.